PAM
GSK icon

Parvin Asset Management’s GSK GSK Stock Holding History

Parvin Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
200
– – 0.01% 278
2026
Q1 		$11K Hold
200
– – 0.01% 276
2025
Q4 		$9.81K Hold
200
– – 0.01% 273
2025
Q3 		$8.63K Hold
200
– – 0.01% 261
2025
Q2 		$7.68K Hold
200
– – 0.01% 270
2025
Q1 		$7.75K Hold
200
– – 0.01% 268
2024
Q4 		$6.76K Buy
+200
New +$7.2K 0.01% 262

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Parvin Asset Management's GSK Position: Q2 2026 in Review

Parvin Asset Management held its GSK (GSK) position steady in Q2 2026 at 200 shares worth $10.5K. The position accounts for 0.01% of the portfolio, ranked #278.

Parvin Asset Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $11K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Parvin Asset Management held 200 shares of GSK worth $10.5K as of Q2 2026.
  • Parvin Asset Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Parvin Asset Management's portfolio in Q2 2026, its #278 holding.
  • Parvin Asset Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Parvin Asset Management's GSK position peaked at $11K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.